biote Corp.
BTMDNASDAQHealthcare● Active
$2.34
+$0.00(+0.00%)
Market Cap$103211637
P/E Ratio—
52W High$4.75
52W Low$1.27
biote Corp. (BTMD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BTMD · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.19B | $0.20B | $0.19B | $0.16B | $0.14B |
| Cost of Revenue | $0.06B | $0.06B | $0.06B | $0.05B | $0.05B |
| Gross Profit | $0.13B | $0.14B | $0.13B | $0.11B | $0.09B |
| Gross Margin %(computed) | 69.76% | 70.52% | 68.78% | 66.92% | 64.98% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.17B | $0.05B |
| Total Operating Expenses | $0.09B | $0.11B | $0.10B | $0.17B | $0.06B |
| Operating Income | $0.04B | $0.03B | $0.03B | ($0.06B) | $0.03B |
| Operating Margin %(computed) | 20.35% | 16.03% | 15.46% | -36.81% | 24.79% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.01B | $0.00B | $0.00B |
| Income Before Tax | $0.04B | $0.00B | ($0.00B) | $0.00B | $0.03B |
| Income Tax Expense | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | $0.03B | $0.00B | $0.00B | ($0.00B) | $0.03B |
| Net Margin %(computed) | 14.07% | 1.60% | 1.79% | -0.59% | 23.40% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $0.86 | $0.09 | $0.13 | $0.16 | $-0.87 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.01B | 0.01B |
| EBITDA | $0.04B | $0.02B | $0.04B | $0.01B | $0.04B |
| EBITDA Margin %(computed) | 22.26% | 7.91% | 21.33% | 4.82% | 25.81% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more biote Corp. data
About biote Corp. (BTMD) Income Statement
biote Corp. (BTMD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BTMD reported revenue of $0.19B, gross profit of $0.13B (gross margin 69.76%), and net income of $0.03B — a net profit margin of 14.07%.
Frequently asked questions
BTMD · 4 questionsbiote Corp. (BTMD) reported revenue of $0.19B for 2025, down 2.5% year-over-year.
BTMD revenueBTMD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09